https://www.selleckchem.com/pr....oducts/ory-1001-rg-6
A more comprehensive multivariate analysis including cancer type, specific gene mutations, and TMB revealed that ICB treatment was an independent predictor of improved overall survival. Therefore, ICB-based therapeutic trials are beneficial in patients with advanced solid malignancies, but the most benefit may be restricted to patients with the right combination of TMB and specific tumor histology and genotype. Copyright © 2020 Yang et al.We investigated on the added prognostic value of a three-scale combined molecular imaging
Like
Comment
Share
